Paul Kling
#177,363
Most Influential Person Now
Violinist
Paul Kling's AcademicInfluence.com Rankings
Download Badge
Communications
Paul Kling's Degrees
- Bachelors Violin Performance Curtis Institute of Music
- Masters Violin Performance Juilliard School
Why Is Paul Kling Influential?
(Suggest an Edit or Addition)According to Wikipedia, Paul Kling was a Czech-born Canadian violinist and Holocaust survivor. Early life Kling was born in Opava on 28 March 1929. He was a gifted musician very early in life, and by age seven he had performed Mozart's A Major Violin Concerto and Bach's A Minor Violin Concerto with the Vienna Symphony Orchestra. In 1941, several months before the thirteen-year-old Kling was to receive the equivalent of a bachelor's degree in musical theory, he was expelled from school for being an 'undesirable element' and associated with the Jewish community.
Paul Kling's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia (2000) (170)
- Neuropeptide Y (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferens. (1985) (103)
- Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones. (1999) (99)
- A new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: comparative potencies and durations of action of nonpeptide antagonists. (1986) (40)
- Bleeding time in rats is prolonged by aspirin. (1977) (25)
- Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series. (1999) (18)
- β2 selective adrenergic responses in the field-stimulated rat vas deferens (1980) (16)
- Pre- and postsynaptic adrenergic activation by norepinephrine reuptake inhibitors in the field-stimulated rat vas deferens. (1981) (16)
- In vitro phamacology of MK‐996, a new potent and selective angiotensin II (AT1) receptor antagonist (1994) (15)
- In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors. (1995) (15)
- Evidence that cholecystokinin octapeptide (CCK-8) acts as a potent, full agonist on gastrin receptors for acid secretion in the isolated mouse stomach: lack of antagonism by the specific CCK antagonist asperlicin. (1986) (14)
- Thyrotropin-releasing hormone receptors in gut tissues resemble pituitary receptors (1986) (12)
- The effect of sulindac and sulindac metabolites on arachidonate-induced lethality in rabbits: effect on human, guinea pig, dog, and rat platelet activity. (1977) (9)
- Characterization of the adrenoreceptor activities of isoprenaline in the field stimulated rat vas deferens: selective supersensitivity to beta 2-mediated responses following reserpine treatment. (1982) (9)
- In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia. (2000) (8)
- High and low (Gpp(NH)p-sensitive) affinity sites for β2-adrenergic blockers as antagonists of isoproterenol in the field-stimulated rat vas deferens (1982) (6)
- Triazolinones as nonpeptide angiotensin II antagonists. 2. discovery of a potent and orally active triazolinone acylsulfonamide (1994) (6)
- The Effect of Halofenate or Halofenate Free Acid on Human, Rat and Guinea Pig Platelet Aggregation (1976) (6)
- Analgesic action of indomethacin in rats with trypsin‐induced hyperalgesia (1980) (5)
- Beta 2 selective adrenergic responses in the field-stimulated rat vas deferens. (1980) (3)
- High and low (Gpp(NH)p-sensitive) affinity sites for beta 2-adrenergic blockers as antagonists of isoproterenol in the field-stimulated rat vas deferens. (1982) (1)
- A new platelet aggregation inhibitor which possesses hypolipemic and uricosuric properties, 2-[3-(2-thiazolylthio)phenyl]propionic acid (TPA). (1979) (1)
This paper list is powered by the following services:
Other Resources About Paul Kling
What Schools Are Affiliated With Paul Kling?
Paul Kling is affiliated with the following schools:
